Ensoma Launches to Pioneer Next-Generation In Vivo Approach to Deliver First “Off-the-shelf” Genomic Medicines
Company’s Engenious™ Vectors Delivered without Stem Cell Collection or Myeloablative Conditioning in Outpatient and Low-resource Settings, Enabling Access Worldwide $70…